The global Animal Drug Compounding Market size was valued at USD 1.7 billion in 2025 and is projected to grow from USD 1.8 billion in 2026 to USD 3.3 billion by 2033, registering a CAGR of 8.5% from 2026 to 2033. North America accounted for the largest revenue share of 37.2% in 2025, driven by advanced veterinary healthcare infrastructure, high pet ownership rates, and increasing...

The global Veterinary Medicine Market is witnessing strong growth due to the increasing livestock population, rising pet ownership, growing prevalence of zoonotic and chronic diseases, and continuous advancements in veterinary pharmaceuticals and biologics. As animal health becomes increasingly important for food security, public health, and companion animal well-being, demand...

The United States Pet Cancer Therapeutics Market is experiencing strong growth driven by rising cases of cancer in companion animals, advanced veterinary healthcare systems, and increasing adoption of specialized oncology treatments. Growing awareness among pet owners regarding cancer treatment options has significantly boosted demand for therapies such as immunotherapy, chemotherapy, and...